These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7338338)

  • 21. Effect of modified tumor antigen on experimentally induced sarcomas.
    Nigam SK; Bhatt VH
    Saudi Med J; 2001 Feb; 22(2):157-63. PubMed ID: 11299413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of immunotherapy and chemotherapy to experimental tumors in rats.
    Hosokawa M; Sendo F; Gotoda E; Kobayashi H
    Gan; 1971 Feb; 62(1):57-60. PubMed ID: 5553381
    [No Abstract]   [Full Text] [Related]  

  • 23. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
    Kennedy RC; Shearer MH; Watts AM; Bright RK
    Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Enhancement of the antitumor transplantation resistance in rats by the antileukemia drug busulfan (author's transl)].
    Mizushima Y
    Hokkaido Igaku Zasshi; 1980 Nov; 55(6):537-42. PubMed ID: 7274985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active-specific immunization against melanoma: is the problem at the receiving end?
    Monsurrò V; Wang E; Panelli MC; Nagorsen D; Jin P; Katia Z; Smith K; Ngalame Y; Even J; Marincola FM
    Semin Cancer Biol; 2003 Dec; 13(6):473-80. PubMed ID: 15001166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytotoxic natural anti-tumor antibodies against fibrosarcoma and glioma cells in rats (author's transl)].
    Itaya T
    Hokkaido Igaku Zasshi; 1981 Sep; 56(5):499-506. PubMed ID: 7319460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced immunogenicity of xenogenized tumor cells in rats pretreated with cyclophosphamide.
    Terishimna M; Takeichi N; Suzuki K; Itaya T; Gotohoda E; Kobayashi H
    Tohoku J Exp Med; 1980 Nov; 132(3):355-61. PubMed ID: 7466815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunological therapy of rat tumors by the tumor cells infected by Friend virus].
    Kaji H; Sendo F; Shirai T; Saito H; Kodama T
    Saishin Igaku; 1969 Jun; 24(6):1329-33. PubMed ID: 5805586
    [No Abstract]   [Full Text] [Related]  

  • 30. Immuno-electron microscopic studies on surface antigens of rat tumor cells infected with Friend virus.
    Kodama T; Gotohda E; Kobayashi H
    Gan; 1973 Oct; 64(5):475-9. PubMed ID: 4769739
    [No Abstract]   [Full Text] [Related]  

  • 31. Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors.
    Ishida T; Oyama T; Carbone DP; Gabrilovich DI
    J Immunol; 1998 Nov; 161(9):4842-51. PubMed ID: 9794417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunotherapy of malignant growths (author's transl)].
    Gericke D
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():350-7. PubMed ID: 88728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of runting syndrome in Friend and Gross virus-induced doubly tolerant rats.
    Takeichi N; Kobayashi H
    Cancer Res; 1980 Feb; 40(2):448-51. PubMed ID: 7356528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naturally arising tumors of the inbred WAB/Not rat strain. II. Immunogenicity of transplanted tumors.
    Middle JG; Embleton MJ
    J Natl Cancer Inst; 1981 Sep; 67(3):637-43. PubMed ID: 6944534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Gal-mediated targeting of human B lymphoma cells to antigen-presenting cells: a potential method for immunotherapy using autologous tumor cells.
    Manches O; Plumas J; Lui G; Chaperot L; Molens JP; Sotto JJ; Bensa JC; Galili U
    Haematologica; 2005 May; 90(5):625-34. PubMed ID: 15921377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The N-terminal flanking region of the invariant chain peptide augments the immunogenicity of a cryptic "self" epitope from a tumor-associated antigen.
    Hess AD; Thoburn C; Chen W; Miura Y; Van der Wall E
    Clin Immunol; 2001 Oct; 101(1):67-76. PubMed ID: 11580228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2.
    McLaughlin JP; Schlom J; Kantor JA; Greiner JW
    Cancer Res; 1996 May; 56(10):2361-7. PubMed ID: 8625312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Unveiling antigens in a non-immunogenic spontaneous murine tumor using a dendritic cell based vaccine].
    Reffo VL; Chiarella P; Bruzzo J; Bustuoabad OD; Ruggiero RA
    Medicina (B Aires); 2008; 68(4):301-4. PubMed ID: 18786887
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity.
    Tüting T; Steitz J; Brück J; Gambotto A; Steinbrink K; DeLeo AB; Robbins P; Knop J; Enk AH
    J Gene Med; 1999; 1(6):400-6. PubMed ID: 10753065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.